Ovoca Bio plc (Ovoca) is an Ireland-based biopharmaceutical company, which is focused on women’s health. The Company is engaged in identifying and developing therapeutics targeting the treatment of female sexual dysfunction. The Company’s product BP101 is a synthetic peptide, administered through a nasal spray that is being developed for the treatment of female sexual dysfunction-hypoactive sexual desire disorder (HSDD). The Company’s subsidiaries include Silver Star Ltd, Bulun LLC, Magsel LLC, IVIX LLC and OVB (Australia) Pty Ltd. The Company operates in Ireland, the United Kingdom (UK) and Russia.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 16.66 | 16.72 | 15.28 | 0.00 | 0.00% | 0.00 | London | |||
| 0.35 | 0.50 | 0.35 | 0.00 | 0.00% | 0.00 | London | |||
| 1,108.00 | 1,112.00 | 1,094.00 | -1.00 | -0.09% | 94.42K | London | |||
| 401.00 | 404.50 | 397.50 | +0.50 | +0.12% | 458.67K | London | |||
| 14.20 | 20.70 | 12.50 | 0.00 | 0.00% | 0.00 | London | |||
| 48.00 | 48.00 | 48.00 | 0.00 | 0.00% | 100.00 | London | |||
| 207.40 | 209.60 | 203.20 | +3.40 | +1.67% | 6.53M | London | |||
| 69.90 | 71.20 | 69.25 | -1.45 | -2.03% | 1.20M | London | |||
| 1,821.00 | 1,832.00 | 1,780.00 | +13.0 | +0.72% | 256.28K | London | |||
| 757.40 | 758.20 | 740.00 | -9.40 | -1.23% | 645.30K | London | |||
| 0.10 | 0.05 | 0.05 | 0.00 | 0.00% | 0.00 | London | |||
| 79.00 | 79.00 | 79.00 | 0.00 | 0.00% | 0.00 | London | |||
| 199.00 | 199.00 | 199.00 | 0.00 | 0.00% | 36.04K | London | |||
| 1,102.00 | 1,117.00 | 1,091.50 | -6.50 | -0.59% | 1.07M | London | |||
| 300.00 | 300.00 | 300.00 | 0.00 | 0.00% | 1.35K | London |